Identification Invasion-Related Long Non-Coding RNAs in Lung Adenocarcinoma and Analysis of Competitive Endogenous RNA Regulatory Networks

References

• World Health Organization. Global health estimates 2020: deaths by cause, age, sex, by country and by region, 2000-2019. Available from: https://who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death. Accessed May 10, 2023.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA Cancer J Clin. 2020 Jul;70(4):313]. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Reck M, Rabe KF. Precision diagnosis and treatment for advanced non-small-cell lung cancer. N Engl J Med. 2017;377(9):849–861. doi:10.1056/NEJMra1703413
   PubMed Web of Science ®Google Scholar
• Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17(3):362–387. doi:10.1016/j.jtho.2021.11.003
   PubMed Web of Science ®Google Scholar
• Zheng Q, Min S, Zhou Q. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases. Biosci Rep. 2021;41(6):BSR20204370. doi:10.1042/BSR20204370
   PubMedGoogle Scholar
• Suhail Y, Cain MP, Vanaja K, et al. Systems biology of cancer metastasis. Cell Syst. 2019;9(2):109–127. doi:10.1016/j.cels.2019.07.003
   PubMed Web of Science ®Google Scholar
• Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5(1):28. doi:10.1038/s41392-020-0134-x
   PubMed Web of Science ®Google Scholar
• Liu J, Jiang C, Xu C, et al. Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma. Cancer Cell Int. 2021;21(1):101. doi:10.1186/s12935-021-01795-1
   PubMed Web of Science ®Google Scholar
• Zheng Z, Deng W, Yang J. Identification of 5-gene signature improves lung adenocarcinoma prognostic stratification based on differential expression invasion genes of molecular subtypes. BioMed Res Int. 2020;2020:8832739. doi:10.1155/2020/8832739
   PubMed Web of Science ®Google Scholar
• Park MK, Zhang L, Min KW, et al. NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis. Cell Metab. 2021;33(12):2380–2397.e9. doi:10.1016/j.cmet.2021.11.011
   PubMed Web of Science ®Google Scholar
• Chakravarty D, Sboner A, Nair SS, et al. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun. 2014;5:5383. doi:10.1038/ncomms6383
   PubMed Web of Science ®Google Scholar
• Xu Y, Li Y, Qiu Y, et al. LncRNA NEAT1 promotes gastric cancer progression through miR-17-5p/TGFβR2 axis up-regulated angiogenesis. Front Cell Dev Biol. 2021;9:705697. doi:10.3389/fcell.2021.705697
   PubMed Web of Science ®Google Scholar
• Shen X, Ye Z, Wu W, et al. lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A/Cul4A and Wnt signaling pathway. Int J Oncol. 2021;59(1):51. doi:10.3892/ijo.2021.5231
   PubMed Web of Science ®Google Scholar
• Wang Z, Zou Q, Song M, Chen J. NEAT1 promotes cell proliferation and invasion in hepatocellular carcinoma by negative regulating miR-613 expression. Biomed Pharmacother. 2017;94:612–618. doi:10.1016/j.biopha.2017.07.111
   PubMed Web of Science ®Google Scholar
• Ding N, Wu H, Tao T, Peng E. NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2. Onco Targets Ther. 2017;10:4905–4915. doi:10.2147/OTT.S142446
   PubMed Web of Science ®Google Scholar
• Li Y, Shen R, Wang A, et al. Construction of a prognostic immune-related LncRNA risk model for lung adenocarcinoma. Front Cell Dev Biol. 2021;9:648806. doi:10.3389/fcell.2021.648806
   PubMed Web of Science ®Google Scholar
• Jiang A, Liu N, Bai S, et al. Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma. J Thorac Dis. 2021;13(2):720–734. doi:10.21037/jtd-20-2803
   PubMed Web of Science ®Google Scholar
• Wang W, He L, Ouyang C, Chen C, Xu X, Ye X. Key common genes in obstructive sleep apnea and lung cancer are associated with prognosis of lung cancer patients. Int J Gen Med. 2021;14:5381–5396. doi:10.2147/IJGM.S330681
   PubMed Web of Science ®Google Scholar
• Gan BL, He RQ, Zhang Y, Wei DM, Hu XH, Chen G. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Int J Oncol. 2018;53(4):1557–1579. doi:10.3892/ijo.2018.4508
   PubMed Web of Science ®Google Scholar
• Sugawara S, Lee JS, Kang JH, et al. Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer. Ann Oncol. 2021;32(9):1137–1147. doi:10.1016/j.annonc.2021.06.004
   PubMed Web of Science ®Google Scholar
• Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297–1325. doi:10.1152/physrev.00041.2015
   PubMed Web of Science ®Google Scholar
• Chen Z, Li JL, Lin S, et al. CAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth. J Clin Invest. 2016;126(6):2267–2279. doi:10.1172/JCI85250
   PubMed Web of Science ®Google Scholar
• Castellano JJ, Navarro A, Viñolas N, et al. LincRNA-p21 impacts prognosis in resected non-small cell lung cancer patients through angiogenesis regulation. J Thorac Oncol. 2016;11(12):2173–2182. doi:10.1016/j.jtho.2016.07.015
   PubMed Web of Science ®Google Scholar
• Navani N, Nankivell M, Lawrence DR, et al. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial. Lancet Respir Med. 2015;3(4):282–289. doi:10.1016/S2213-2600(15)00029-6
   PubMed Web of Science ®Google Scholar
• Mu L, Ding K, Tu R, Yang W. Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma. J Transl Med. 2021;19(1):127. doi:10.1186/s12967-021-02800-x
   PubMed Web of Science ®Google Scholar
• Wang L, He Y, Liu W, et al. Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer. Oncotarget. 2016;7(10):11487–11499. doi:10.18632/oncotarget.7203
   PubMedGoogle Scholar
• Wang L, Cao L, Wen C, Li J, Yu G, Liu C. LncRNA LINC00857 regulates lung adenocarcinoma progression, apoptosis and glycolysis by targeting miR-1179/SPAG5 axis. Hum Cell. 2020;33(1):195–204. doi:10.1007/s13577-019-00296-8
   PubMed Web of Science ®Google Scholar
• Zhou D, He S, Zhang D, et al. LINC00857 promotes colorectal cancer progression by sponging miR-150-5p and upregulating HMGB3 (high mobility group box 3) expression. Bioengineered. 2021;12(2):12107–12122. doi:10.1080/21655979.2021.2003941
   PubMed Web of Science ®Google Scholar
• Zhang K, Shi H, Xi H, et al. Genome-wide lncRNA microarray profiling identifies novel circulating lncRNAs for detection of gastric cancer. Theranostics. 2017;7(1):213–227. doi:10.7150/thno.16044
   PubMed Web of Science ®Google Scholar
• Li Y, Sheng H, Ma F, et al. RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/β-catenin signaling. Cell Death Dis. 2021;12(5):479. doi:10.1038/s41419-021-03763-z
   PubMed Web of Science ®Google Scholar
• Xue Y, Diao M, Lyu J, et al. Long noncoding RNAs PTPRG antisense RNA 1 targets cyclin D1 to facilitate cell proliferation in lung adenocarcinoma. Cancer Biother Radiopharm. 2021. doi:10.1089/cbr.2021.0168
   Web of Science ®Google Scholar
• Nagaoka K, Fujii K, Zhang H, et al. CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis. Oncogene. 2016;35(22):2893–2901. doi:10.1038/onc.2015.350
   PubMed Web of Science ®Google Scholar
• Wang J, Yu XF, Ouyang N, et al. MicroRNA and mRNA interaction network regulates the malignant transformation of human bronchial epithelial cells induced by cigarette smoke. Front Oncol. 2019;9:1029. doi:10.3389/fonc.2019.01029
   PubMed Web of Science ®Google Scholar
• Herrington J, Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab. 2001;12(6):252–257. doi:10.1016/s1043-2760(01)00423-4
   PubMed Web of Science ®Google Scholar
• Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3(70):70ra13. doi:10.1126/scitranslmed.3001845
   PubMed Web of Science ®Google Scholar
• Liu Z, Cui Y, Wang S, et al. MiR-96-5p is an oncogene in lung adenocarcinoma and facilitates tumor progression through ARHGAP6 downregulation. J Appl Genet. 2021;62(4):631–638. doi:10.1007/s13353-021-00652-1
   PubMed Web of Science ®Google Scholar
• Wang G, Ji X, Li P, Wang W. Human bone marrow mesenchymal stem cell-derived exosomes containing microRNA-425 promote migration, invasion and lung metastasis by down-regulating CPEB1. Regen Ther. 2022;20:107–116. doi:10.1016/j.reth.2022.03.007
   PubMed Web of Science ®Google Scholar
• Zhao J, Li G, Zhao G, et al. Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma. Front Oncol. 2022;12:986367. doi:10.3389/fonc.2022.986367
   PubMedGoogle Scholar
• Pan X, Zhong A, Xing Y, Li X, Du H, Shi M. A novel GHR-ALK fusion gene in a patient with metastatic lung adenocarcinoma and its response to crizotinib: a case report. J Int Med Res. 2021;49(9):3000605211044652. doi:10.1177/03000605211044652
   Web of Science ®Google Scholar